Dr. Oommen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1479 Ygnacio Valley Rd
# 200
Walnut Creek, CA 94598Phone+1 925-296-7340
Education & Training
- One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Surgery, 1978 - 1982
- St John's Episcopal Hospital-South ShoreInternship, Surgery, 1977 - 1978
- Karnataka Institute of Medical ScienceClass of 1974
Certifications & Licensure
- NY State Medical License 1980 - Present
- CA State Medical License 1987 - 2026
- TX State Medical License 1985 - 1988
- American Board of Colon and Rectal Surgery Colon & Rectal Surgery
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
- RObotic Versus LAparoscopic Resection for Rectal Cancer Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 89 citationsConsolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: Final results of a multicenter phase II ...Michael R. Marco, Lihong Zhou, Sujata Patil, Jorge E. Marcet, Madhulika G. Varma
Diseases of the Colon and Rectum. 2018-10-01 - 207 citationsOrgan preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, ...Julio Garcia-Aguilar, Lindsay A. Renfro, Oliver S. Chow, Qian Shi, Xiomara W. Carrero
The Lancet. Oncology. 2015-11-01 - 414 citationsEffect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trialJulio Garcia-Aguilar, Oliver S. Chow, David D. Smith, Jorge E. Marcet, Peter A. Cataldo
The Lancet. Oncology. 2015-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: